Home Feedback Contents Search Contacts Publications FAQ Support About Us

Multicase Inc Bioactivity Software

                                     

Home
News
Products
Consulting
Request Info

 

 

 

 

 

 

 

 

 

Welcome to MultiCASE Inc, the leading provider of  artificial intelligence based bioactivity software, expert systems and in-silico consulting services for the Chemical and  Pharmaceutical Industries

Our Mission

We develop and license computer programs designed to help the user to assess the potential adverse effects and metabolic properties of new chemicals both in virtual laboratory animals and in the environment. We also offer consulting services related to these issues as required for REACH submissions.

Company Profile

MultiCASE Inc. (formerly BIOSOFT Inc.) is a Software company started in Cleveland Ohio in 1996. The principal is Gilles Klopman, the Charles F. Mabery Professor of Chemistry at Case Western Reserve University (CWRU). Its business is to develop and license programs for use by chemical and pharmaceutical companies to design new useful molecules and to evaluate their impact on the environment at an early stage of development.  The data for many of our expert systems have been developed by the US Food and Drug Administration ICSAS office and is used by many government regulatory agencies such as US, Canadian, Japan, Danish and the OECD in conjunction with the REACH program..

Latest News

bulletToxExpo2009 in Baltimore. Please visit us in our booth 3144.
bulletWe have acquired a certification in "Chemical Safety Assessment under REACH" and are offering consulting services for REACH submissions and dossier preparation.
bulletWe have acquired a new set of FDA ICSAS human adverse effect modules: Hepatobiliary, Renal and Urinary Tract and Cardiac Adverse Effects in Humans
bulletMultiCASE inc has joined Insilico First, a unique collaborative endeavor, working to develop a pioneering computational prediction system to support the environmental safety assessment of chemicals.  June 1st, 2008.
bulletVersion 2.0 of our software products has been released on May 15, 2008
bulletWe have acquired a new set of FDA ICSAS teratogenicity modules.
bulletList of modules was updated to include all newly acquired and updated in 2006 modules.
bulletMCWeb - an online version of MC4PC and CaseTox was launched.
bulletACS Expo in Atlanta. See details.
bulletToxExpo2006 in San Diego. See details.
bulletToxExpo2005 in New Orleans. See details.
bulletFifth contributor joined our Mutagenicity Data Sharing consortium. See details.
bulletRenewed CRADA with the FDA...See details.
bulletFirst release of ToxLite - the most affordable version of CASETOX. See details.

[ Home ] Feedback ] Contents ] Search ] Contacts ] Publications ] FAQ ] Support ] About Us ]

Send mail to saiakhov@multicase.com with questions or comments about this web site.
Copyright © 2010 Multicase Inc
Last modified: 01/04/10

MultiCASE MC4PC-based computational toxicology estimations are intended to be used as part of a weight of evidence approach for hazard and risk assessment that includes laboratory experimental data. Computational toxicology predictions are not intended as a substitute for appropriate animal or clinical studies. Results obtained with certain MC4PC software modules should be regarded as preliminary and subject to change.